MTOR
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Everolimus for Cancer With TSC1 or TSC2 Mutation (NCT02201212) | Dana-Farber Cancer Institute | 2014-09-01 |
| Tamoxifen Treatment in Patients With Motor Neuron Disease (NCT02166944) | Taipei Medical University Shuang Ho Hospital | 2014-04-01 |
Track MTOR automatically
Every clearance here is in the API, with alerts when new ones post.